106 related articles for article (PubMed ID: 1702184)
1. [Synthesis of hepatitis B virus core antigen (HBcAg) particles by recombinant vaccinia virus].
Loparev VN; Araslanov RR; Mitina IV; Antonova TP; Ianova NN; Iashina TL; Chernos VI
Mol Gen Mikrobiol Virusol; 1990 Oct; (10):18-22. PubMed ID: 1702184
[No Abstract] [Full Text] [Related]
2. [Hepatitis B core antigen as a carrier of functionally active epitopes: exposure of pre-S sites on capsids].
Borisova GP; Berzin' IG; Tsibinogin VV; Loseva VIa; Pushko PM; Ose VP; Dreĭlina DE; Pumpen PP; Gren EIa
Dokl Akad Nauk SSSR; 1990; 312(3):751-4. PubMed ID: 1699713
[No Abstract] [Full Text] [Related]
3. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
4. Stability governs the apparent expression of "particulate" hepatitis B e antigen by mutant hepatitis B virus core particles.
Seifer M; Standring DN
Virology; 1993 Sep; 196(1):70-8. PubMed ID: 7689282
[TBL] [Abstract][Full Text] [Related]
5. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
[TBL] [Abstract][Full Text] [Related]
6. DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice.
Kuhöber A; Pudollek HP; Reifenberg K; Chisari FV; Schlicht HJ; Reimann J; Schirmbeck R
J Immunol; 1996 May; 156(10):3687-95. PubMed ID: 8621903
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.
Ulrich R; Borisova GP; Gren E; Berzin I; Pumpen P; Eckert R; Ose V; Siakkou H; Gren EJ; von Baehr R
Arch Virol; 1992; 126(1-4):321-8. PubMed ID: 1381912
[TBL] [Abstract][Full Text] [Related]
8. The core antigen of hepatitis B virus as a carrier for immunogenic peptides.
Murray K; Shiau AL
Biol Chem; 1999 Mar; 380(3):277-83. PubMed ID: 10223329
[TBL] [Abstract][Full Text] [Related]
9. Expression of hepatitis B core antigen gene in recombinant vaccinia virus.
Han SW; Zhu QY; Zhao LQ; Fang JM
Chin J Biotechnol; 1989; 5(3):141-8. PubMed ID: 2491322
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
[TBL] [Abstract][Full Text] [Related]
11. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
12. Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.
NAM JH; BANG HS; CHO HW; CHUNG YH
Acta Virol; 2007; 51(2):125-30. PubMed ID: 17900219
[TBL] [Abstract][Full Text] [Related]
13. [Exposition of epitopes of transmembrane protein gp41 of the human immunodeficiency virus on surface capsids of the hepatitis B virus core antigen].
Yl'rikh R; Borisova GP; Mering R; Létch I; Ose VP; Berzin' IG; Dreĭlinia DE; Pushko PM; Tsibinogin VV; Pumpen PP
Bioorg Khim; 1990 Sep; 16(9):1283-6. PubMed ID: 1706924
[No Abstract] [Full Text] [Related]
14. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants.
Cañizares MC; Lomonossoff GP; Nicholson L
Expert Rev Vaccines; 2005 Oct; 4(5):687-97. PubMed ID: 16221070
[TBL] [Abstract][Full Text] [Related]
15. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice.
Huang Z; Santi L; LePore K; Kilbourne J; Arntzen CJ; Mason HS
Vaccine; 2006 Mar; 24(14):2506-13. PubMed ID: 16417953
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.
Ye WW; Mason BB; Chengalvala M; Cheng SM; Zandle G; Lubeck MD; Lee SG; Mizutani S; Davis AR; Hung PP
Arch Virol; 1991; 118(1-2):11-27. PubMed ID: 1828660
[TBL] [Abstract][Full Text] [Related]
17. Generation of chimeric HBc proteins with epitopes in E.coli: formation of virus-like particles and a potent inducer of antigen-specific cytotoxic immune response and anti-tumor effect in vivo.
Zhang Y; Song S; Liu C; Wang Y; Xian X; He Y; Wang J; Liu F; Sun S
Cell Immunol; 2007 May; 247(1):18-27. PubMed ID: 17707782
[TBL] [Abstract][Full Text] [Related]
18. [Bacterial synthesis of immunogenic epitopes of foot-and-mouth disease virus fused either to human necrosis factor or to hepatitis B core antigen].
Nekrasova OV; Boĭchenko VE; Boldyreva EF; Borisova GP; Pumpen P; Perevozchikova NA; Korobko VG
Bioorg Khim; 1997 Feb; 23(2):118-26. PubMed ID: 9157845
[TBL] [Abstract][Full Text] [Related]
19. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis B virus core protein as an epitope vaccine carrier: a review].
Yin Y; Xu J; Chen W
Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):431-8. PubMed ID: 20575429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
